Position in PFE
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$963
-$160 QoQ
Shares Held
40
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,805
of 2,821 holders
Holding Since
Mar 2025
6 quarters on record
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Barnes Dennig Private Wealth Management LLC holds $5,736,570 across 9 Drug Manufacturers - General names. PFE ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
11,393 | $4,125,633 | |
| 2 | LLY |
ELI LILLY & Co
|
646 | $774,831 | |
| 3 | JNJ |
Johnson & Johnson
|
2,443 | $620,448 | |
| 4 | NVS |
Novartis AG
|
1,060 | $166,123 | |
| 5 | MRK |
Merck & Co., Inc.
|
335 | $43,047 | |
| 6 | NVO |
Novo Nordisk A S
|
68 | $3,259 | |
| 7 | BIIB |
Biogen Inc.
|
7 | $1,512 | |
| 8 | PFE |
Pfizer Inc
This page
|
40 | $963 |
All Filings in PFE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $963 | 40 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $1,123 | 40 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $996 | 40 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,019 | 40 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $969 | 40 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $38,618 | 1,524 | Shares | Sole | 2025-04-25 | |
| No filing history on record for this holder in this stock. | ||||||